REFERENCES
  1. Yoshimi A, Kojima S, Hirano N. Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations. Pediatr Drugs 2010;12:11-21.
  2. Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization Criteria and point-of-care diagnostic algorithms. Leukemia 2008;22:14-22.
  3. Chan RJ, Cooper T, Kratz CP, Weiss B, Loh ML. Juvenile myelomonocytic leukemia: a report from the 2nd international JMML symposium. Leuk Res 2009;33:355-62.
  4. Yoshida N, Hirabayashi S, Watanabe S, et al. Prognosis of 75 patients with juvenile myelomonocytic leukemia: prospective study by MDS committee in the Japanese Society of Pediatric Hematology. Rinsho Ketshueki 2011;52:1853-8.
  5. Niemeyer CM, Arico M, Basso G, et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 1997;89:3534-43.
  6. Sakashita K, Matsuda K, Koike K. Diagnosis and treatment of juvenile myelomonocytic leukemia. Pediatrics International 2016;58:681-90.
  7. Yabe M, Ohtsuka Y, Watanabe K, Inagaki J, Yoshida N, Sakashita K, et al. Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan. Int J Hematol 2015;101:184–90.
  8. Dvorak CC, Loh ML. Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantation. Front Pediatr 2014;25.eCollection.
  9. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Healt Organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127:2391-2405.
  10. Locatelli F, Algeri M, Merli P, Strocchio L. Novel approaches to diagnosis and treatment of juvenile myelomonocytic leukemia. Expert Rev Hematol 2018;11:129-43.
  11. Locatelli F, Nolke P, Zecca M, Korthof E, Lanino E, Peters C, et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2005;105:410-19.
  12. Honda Y, Tsuchida M, Zaike Y, Masunaga A, Yoshimi A, Kojima S, et al. Clinical characteristics of 15 children with juvenile myelomonocytic leukaemia who developed blast crisis: MDS Committee of Japanese Society of Paediatric Haematology/Oncology. Br J Haematol 2014;165:682–7.
  13. Gupta DK, Meena JP, Chopra A, Tanwar P, Seth R. Juvenile myelomonocytic leukemia-a comprehensive review and recent advances in management. Am J Blood Res 2021;11:1-21.
  14. Bergstraesser E, Hasle H, Rogge T, Fischer A, Zimmerman M, et al. Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria. Pediatr Blood Cancer 2007;49:629–33. https://doi. org/10.1002/pbc.21038.
  15. Niemeyer CM, Kratz C. Juvenile myelomonocytic leukemia. Curr Oncol Rep 2003;5:510–15.
  16. Sakashita K, Matsuda K, Koike K. Diagnosis and treatment of juvenile myelomonocytic leukemia. Pediatr Int 2016;58:681–90.
  17. Jin Kang H, Young Sin H, Soo Choi H, Seop Ahn H. Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML). Leukemia Research 2004;28:167-70.
  18. Feng X, Peng Z, He Y, Li C, Ruang Y, Liu X, et al. Improvement of survival in JMMLl by induction regimen of decitabine + cytarabine + fludarabine before hematopoietic stem cell transplantation: study of 33 cases in single center. Blood 2019;134(suppl):4267.
  19. Cseh A, Niemeyer CM, Yoshimi A, Dworzak M, Hasle H, van den Heuvel-Eibrink MM, et al. Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood 2015;125:2311–3.
  20. Leoncini PP, Vitullo P, Di Florio F, Tocco V, Cefalo MG, Pitisci A, et al. Whole Genome MBD-seq reveals different CpG methylation patterns in Azacytidine-treated juvenile myelomonocytic leukemia (JMML) patients. Br J Haematol 2018;182:909-12.
  21. Fabri O, Horakova J, Bodova I, Svec P, LaluhovaStriezencova Z, et al. Diagnosis and treatment of juvenile myelo-monocytic leukemia in the Slovak Republic: novel approaches. Neoplasma 2019;66:818- 24.
  22. World Health Organization. Definitions of palliative care. Geneva; 2002; 2017.
  23. Committee on Hospital Care and Institute for Patient-and Family-Centered Care. Patient-and-family centered care and the pediatrician’s role. Pediatrics 2012;129: 394-404.
  24. Feudtner C, Friebert S, Jewell J, Carter B, Hood M, Imaizumi S, et al. Pediatric palliative care and hospice care commitments, guidelines, and recommendations. Pediatrics 2013;132:966-72.
  25. Doherty M, Thabet C. Development and implementation of a pediatric palliative care program in a developing country. Frontiers Pub Health 2018;6: doi: 10.3389/fpubh.2018.00106.